Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NovaScreen Biosciences

1986 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of laboratory and digital discovery and development tools intended to focus on in vitro & in vivo discovery services. The company's services include drug discovery screening, in vitro compound profiling and assay development for safety assessment, enabling drug industry to make innovative services and database products to improve the productivity, accelerate the pace and reduce the cost of pharmaceutical research and development.

Formerly Known As
Oceanix Biosciences Corporation
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 7170 Standard Drive
  • Hanover, MD 21076
  • United States

NovaScreen Biosciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore NovaScreen Biosciences‘s full profile, request access.

Request full access to PitchBook

NovaScreen Biosciences Executive Team (1)

Name Title Board
Seat
Contact
Info
David Manyak Chief Executive Officer